關鍵數據
1.350今開
1.640最高
12.49K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.10%換手率
1.360昨收
1.345最低
17.60K成交額
虧損本益比靜
-5.47市淨率
0.00%股息率 TTM
-112.37%ROA
4.70352週最高
0.03量比
-20.78M淨利潤
12.76M總股本
-1.4460每股盈餘TTM
2.27Beta
-157.37%ROE
1.11052週最低
21.69%振幅
--毛利率
17.74M總市值
-1.69回報/風險
6.21%風險率

即將為您帶來更多新聞,敬請期待。 。 。
分析師評級
買入評級
17.500目標均價
+1186.76%漲幅空間
Lantern Pharma Inc 最新財報電話會記錄
Lantern Pharma (LTRN) 2026年第二季財報電話會議:營業虧損減少,LP-300 與 Open Medicine AI
Lantern Pharma 2026 年第二季財報電話會議:營業虧損下降 25% 至 350 萬美元,現金為 740 萬美元,同時 LP-300 與 Open Medicine AI 取得進展。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
Lantern Pharma Inc 簡介
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 100 billion oncology-focused data points and a library of over 200+ advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.
行業生物技術與醫療研究
公司代碼LTRN
員工數量24
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Biological Mimetics, Inc | 7.47% |
|---|
| Bios Equity Partners, LP. | 7.38% |
|---|
| Prophase Labs Inc | 5.58% |
|---|
| Satterfield (Thomas A Jr) | 5.04% |
|---|
| 股東類型 | 佔比 |
|---|
| Corporation | 13.05% |
|---|
| Investment Advisor | 7.58% |
|---|
| Venture Capital | 7.38% |
|---|
| Individual Investor | 5.45% |
|---|
常見問題
Lantern Pharma Inc(LTRN)的當前股價是多少?
Lantern Pharma Inc(LTRN)的當前股價是 1.36。
Lantern Pharma Inc 的股票代碼是什麼?
Lantern Pharma Inc的股票代碼是LTRN。
Lantern Pharma Inc股票的52週最高點是多少?
Lantern Pharma Inc股票的52週最高點是4.70。
Lantern Pharma Inc股票的52週最低點是多少?
Lantern Pharma Inc股票的52週最低點是1.11。
Lantern Pharma Inc的市值是多少?
Lantern Pharma Inc的市值是17.35M。
現在Lantern Pharma Inc(LTRN)的股票是買入、持有還是賣出?
根據分析師評級,Lantern Pharma Inc(LTRN)的總體評級為買入,目標價格為17.50。
Lantern Pharma Inc(LTRN)股票的每股收益(EPS TTM)是多少
Lantern Pharma Inc(LTRN)股票的每股收益(EPS TTM)是-1.45。